IMPROVING THE PRIORITIZATION PROCEDURE OF PATIENTS WITH COVID-19 IN HOSPITALS BASED ON DECISION-MAKING TECHNIQUES: A SYSTEMATIC REVIEW

Abstract

Coronavirus-specific antibodies can be detected in the blood of people who have recently recovered from coronavirus disease-2019 (COVID-19). Convalescent-Plasma (CP) transfusion process proved that it's among the most efficient protocols, and it's used in hospitals to treat various infections and diseases. Several medical issues have been addressed due to the growing interest in creating Artificial Intelligence (AI) applications. However, considering the virus's enormous potential harm to global public health, such uses are insufficient. This proposed systematic review and meta-analysis aims to obtain an overview of COVID-19, highlight the limits of decision-making approaches, and give healthcare professionals information about the technique's advantages. Between 2016 and 2021, five databases, namely IEEE Xplore, Web of Science, PubMed, Science Direct, and Scopus, were utilized to run four sequences of search queries. As a result, 477 studies are found to be relevant. Only six studies were thoroughly examined and included in this review after screening articles and using proper inclusion criteria, highlighting the lack of research on this crucial topic. Studies' findings were reviewed to identify the gaps in all the evaluated papers. Motivations, problems, constraints, suggestions, and case examples were thoroughly examined. This study seeks to answer how we support the researchers with collected information for managing transfusion of the highest quality CP to the most critical COVID-19 patients across telemedicine hospitals.

Keywords

• convalescent-plasma
• covid-19
• mcdm
• telemedicine
• prioritization